Resmed's total assets for Q2 2026 were $8.50B, an increase of 2.35% from the previous quarter. RMD total liabilities were $2.18B for the fiscal quarter, a -0.21% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.